Cancer Clinical Trial
Official title:
Enhancing Adjustment to Parental Cancer: Short-term Counselling for Families. A Randomized, Wait-list Controlled Intervention Study
Verified date | July 2020 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A parental cancer diagnosis challenges the family's stability and the parent-child
relationship. It may impact the children's well-being, so that about one third of them
develop clinically relevant levels of psychological distress. Psycho-oncological family-based
counselling programs have been shown to elevate children's and parents' well-being. However,
there is still a dearth of familial health services in Switzerland, which has also been
recognized by the Swiss National Cancer Program (2011-2017).
This study aims to implement and evaluate a short-term family counselling intervention at the
Cancer Center of the University Hospital Basel. The primary objective of the study is the
enhancement of adjustment to the parental cancer diagnosis. The study seeks secondary to
determine the feasibility of the short-term counselling Intervention.
Status | Completed |
Enrollment | 11 |
Est. completion date | September 1, 2019 |
Est. primary completion date | September 1, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Months and older |
Eligibility |
Inclusion Criteria: - Informed Consent as documented by signature - Diagnosis of any kind of cancer, inclusive relapse, within the last year with an expected survival of at least 8 months - Married, cohabiting or single parent - At least one child between 1-5 - 18 years - German speaking Exclusion Criteria: - The diagnosis is more than 1 year ago - Diagnosed patients (parent) not living with their children - Diagnosed patients without custody of their children |
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Basel | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland | propatient Forschungsstiftung |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of children's quality of life on the health-related quality of life questionnaire (KINDL) | Enhancement of children's quality of life from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. | 6 weeks (change between baseline and week 6) | |
Primary | Change of children's behavioral-emotional functioning on the Strengths and Difficulties Questionnaire (SDQ) | Enhancement of children's behavioral-emotional functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. | 6 weeks (change between baseline and week 6) | |
Primary | Change of parent's mental health on the Hospital Anxiety and Depression Scale (HADS) | Enhancement of parent's mental health from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. | 6 weeks (change between baseline and week 6) | |
Primary | Change of family functioning on the Family Adaptability and Cohesion Evaluation Scale (FACES IV) | Enhancement of family functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. | 6 weeks (change between baseline and week 6) | |
Primary | Change of relationship quality on the relationship questionnaire (Partnerschaftsfragebogen PFB) | Enhancement of relationship quality from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. | 6 weeks (change between baseline and week 6) | |
Secondary | Number of participants willing to participate in the counselling | Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting the number of participants willing to participate. | Through study completion, an average of 2 years | |
Secondary | Sociodemographic characteristics (i.e. age, gender, education) of the participants willing to participate in the counselling with the sociodemographic questionnaire | Collecting sociodemographic characteristics of the population willing to participate with the sociodemographic questionnaire | Through study completion, an average of 2 years | |
Secondary | Medical history characteristics (i.e. cancer diagnosis, cancer treatment) of the participants willing to participate in the counselling with the medical history questionnaire | Collecting medical history of the population willing to participate with the medical history questionnaire | Through study completion, an average of 2 years | |
Secondary | Dropout rate during the recruitment and intervention procedure | Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting dropout rate during the recruitment and intervention procedure. | Through study completion, an average of 2 years | |
Secondary | Client satisfaction on the Client Satisfaction Questionnaire (CSQ-8) | German Version of the Client Satisfaction Questionnaire: Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be used to measure client's intervention satisfaction. | Measures assessed after 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|